Factor | No. of Anti-HCV+ / No. of Tested | % | Univariate | Multivariable†| ||
---|---|---|---|---|---|---|
Crude OR (95% CI) | p | Adjusted OR (95% CI) | p | |||
Population | 3990 | Â | Â | Â | Â | Â |
 Heterosexual | 20/849 | 2.4 | Reference |  | Reference |  |
 MSM | 136/2923 | 4.7 | 2.02 (1.26 to 3.25) | 0.004 | 2.11 (1.26 to 3.55) | 0.005 |
 TGW | 8/214 | 3.7 | 1.61 (0.70 to 3.71) | 0.263 | 1.78 (0.74 to 4.30) | 0.199 |
 TGM | 0/4 | 0.0 | – | – | – | – |
Age | 3990 | Â | Â | Â | Â | Â |
  ≤ 30 | 89/2541 | 3.5 | Reference |  | Reference |  |
  > 30 | 75/1449 | 5.2 | 1.51 (1.10 to 2.06) | 0.011 | 1.54 (1.10 to 2.17) | 0.012 |
Monthly income (baht) | 1330 | Â | Â | Â | Â | Â |
  ≤ 10,000 | 8/256 | 3.1 | Reference |  |  |  |
  > 10,000 | 54/1074 | 5.0 | 1.64 (0.77 to 3.49) | 0.199 |  |  |
Residential location | 1999 | Â | Â | Â | Â | Â |
 Bangkok | 66/1367 | 4.8 | Reference |  |  |  |
 Outside Bangkok | 33/632 | 5.2 | 1.09 (0.71 to 1.67) | 0.706 |  |  |
Educational level | 2301 | Â | Â | Â | Â | Â |
 College or above | 85/1514 | 5.6 | Reference | 0.022 |  |  |
 High school or below | 27/787 | 3.4 | 0.60 (0.38 to 0.93) |  |  |  |
CD4 count (cells/mm3) | 3985 | Â | Â | Â | Â | Â |
  < 200 | 37/1027 | 3.6 | Reference |  |  |  |
  ≥ 200 | 126/2958 | 4.3 | 1.19 (0.82 to 1.73) | 0.360 |  |  |
ALT (U/L) | 3975 | Â | Â | Â | Â | Â |
  < 62.5 | 98/3623 | 2.7 | Reference |  | Reference |  |
  ≥ 62.5 | 64/352 | 18.2 | 7.99 (5.71 to 11.2) | <  0.001 | 7.74 (5.48 to 10.9) | <  0.001 |
CrCl (ml/min) | 3923 | Â | Â | Â | Â | Â |
  < 60 | 5/29 | 17.2 | 5.03 (1.89 to 13.3) | 0.001 | 5.58 (1.95 to 16.0) | 0.001 |
  ≥ 60 | 155/3894 | 4.0 | Reference |  | Reference |  |
Syphilis | 3965 | Â | Â | Â | Â | Â |
 Negative | 109/3203 | 3.4 | Reference |  | Reference |  |
 Positive | 54/762 | 7.1 | 2.16 (1.55 to 3.03) | <  0.001 | 1.95 (1.36 to 2.78) | <  0.001 |